Research Article
Clinical Aspects and Prognosis Evaluation of Cirrhotic Patients Hospitalized with Acute Kidney Injury
Table 3
Comparison of demographic, clinical, and laboratory screening variables at the end of the first month.
| | Survivors (n=35) | Nonsurvivors (n = 14) | p value |
| Demographic | | | | Age | 54.6 (±11.6) | 55 (±8.7) | 0.915 | Men | 24 (68.6%) | 10 (71.4%) | 0.845 | Women | 11 (31.4%) | 4 (28.6%) | Clinical | | | | Child-Pugh | 9.9(±2.1) | 11.3(±1.5) | 0.019 | MELD | 20.4 (±6.0) | 25.1 (±8.7) | 0.034 | MELD-Na | 23.1 (±6.4) | 27.6 (±7.3) | 0.037 | ICA-AKI Stage | | | 0.269 | 1 | 20 (57.1%) | 8 (57.1%) | | 2 | 10 (28.6%) | 6 (42.9%) | | 3 | 5 (14.3%) | 0 | | Subdivision of stage 1 (n=28) | | | 0.791 | 1a | 6 (30%) | 2 (25%) | | 1b | 14 (70%) | 6 (75:%) | | AKI causes | | | 0.609 | Infection | 14 (40%) | 7 (50%) | | Hypovolemia | 11 (31.4%) | 4 (28.6%) | | Hepatorenal syndrome | 2 (5.7%) | 2 (14.3%) | | Nephropathy | 2 (5.7%) | 0 | | Miscellaneous | 2 (5.7%) | 1 (7.1%) | | Multiple | 4 (11.4%) | 0 | | Response to expansion treatment | | | | Complete | 24 (68.6%) | 4 (28.6%) | 0.001 | Partial | 7 (20%) | 1 (7.1%) | | Absent | 4 (11.4%) | 9 (64.3%) | | Encephalopathy | | | | Present | 10 (28.6%) | 4 (28.6%) | 1.0 | Absent | 25 (71.4%) | 10 (71.4%) | | Ascites | | | | Present | 29 (82.9%) | 12 (92.9%) | 0.366 | Absent | 6 (17.1%) | 1 (7.1%) | | Laboratory | | | | Creatinine (mg/dL) | 2.2(±1.0) | 1.8(±0.6) | 0.165 | Total bilirrubin (mg/dL) | 1.72 (0.3-19.4) | 6 (1.1-23.9) | 0.028 | Albumin (g/dL) | 2.5 (±0.5) | 2.4 (±0.5) | 0.567 | INR | 1.5 (1.0-3.0) | 2.0 (1.1-6.0) | 0.012 | Sodium (mEq/L) | 133.2 (±5.4) | 134.8 (±4.3) | 0.329 | C-Reactive Protein (mg/L) | 30 (5-287) | 31(13-197) | 0.748 |
|
|
ICA-AKI, International Club of Ascites–Acute Kidney Injury.
|